Concepedia

Silvia Shardonofsky

SS

Statistics

Publications

4

Citations

98

H-Index

4

Active since

2022

Affiliations

Vertex Pharmaceuticals (Canada)(Current)

Cornell University

St George's, University of London

Piedmont Atlanta Hospital

NewYork–Presbyterian Hospital

Silvia Shardonofsky is an author at Vertex Pharmaceuticals (Canada) specializing in pharmacovigilance, intranasal administration, and cardiovascular pharmacotherapy.

Publications per year

2022–2023

4

Publications

4

First Randomized, Multicenter, Placebo-Controlled Study of Self-Administered Intranasal Etripamil for Acute Conversion of Spontaneous Paroxysmal Supraventricular Tachycardia (NODE-301)

Bruce S. Stambler, Francis Plat, Philip T. Sager et al. · Circulation Arrhythmia and Electrophysiology · 2022 · 39 citations · Full text

, , +17

Self-administered intranasal etripamil using a symptom-prompted, repeat-dose regimen for atrioventricular-nodal-dependent supraventricular tachycardia (RAPID): a multicentre, randomised trial

Bruce S. Stambler, A. John Camm, Marco Alings et al. · The Lancet · 2023 · 36 citations · Full text

, , +17

Multicenter, Phase 2, Randomized Controlled Study of the Efficacy and Safety of Etripamil Nasal Spray for the Acute Reduction of Rapid Ventricular Rate in Patients With Symptomatic Atrial Fibrillation (ReVeRA-201)

A. John Camm, Jonathan P. Piccini, Marco Alings et al. · Circulation Arrhythmia and Electrophysiology · 2023 · 13 citations · Full text

, , +17

Etripamil Nasal Spray for Conversion of Repeated Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia During Long‐Term Follow‐Up: Results From the NODE‐302 Study

James E. Ip, Benoit Coutu, Matthew T. Bennett et al. · Journal of the American Heart Association · 2023 · 10 citations · Full text

, , +15

1–4 of 4